NCT00424242
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +112 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
Clinical trial condition
Leukemia, Mast-Cell
Explore clinical trials studying Leukemia, Mast-Cell. Study availability and eligibility vary by location and protocol.
43 public trials
5 recruiting studies
Leukemia, Mast-Cell trial results
NCT02620254
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
- Locations
-
- Registry participation is worldwide and not limited to this facility Cambridge, Massachusetts, United States
NCT01869777
- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +27 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
NCT00750009
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
NCT00014235
- Conditions
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Conditions
- Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
Completed
Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
NCT01807598
- Conditions
- Aggressive Systemic Mastocytosis, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00782067
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
- Locations
-
- University of California at Los Angeles Dept. of Hematology Clinic Los Angeles, California, United States
- Stanford University Medical Center Stanford University 2 Stanford, California, United States
- Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States
- Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
NCT00233454
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +19 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Washington University-St. Louis St Louis, Missouri, United States
NCT01273766
- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States